P
MDGL icon

Pitcairn’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pitcairn’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-771
Closed -$354K – 336
2025
Q3 		$354K Sell
771
-25
-3% -$9.33K 0.03% 447
2025
Q2 		$241K Sell
796
-183
-19% -$54.5K 0.02% 626
2025
Q1 		$324K Sell
979
-81
-8% -$26.6K 0.02% 560
2024
Q4 		$327K Buy
1,060
+33
+3% +$9.28K 0.02% 559
2024
Q3 		$218K Sell
1,027
-64
-6% -$16.4K 0.01% 671
2024
Q2 		$306K Buy
1,091
+84
+8% +$20K 0.02% 583
2024
Q1 		$269K Buy
+1,007
New +$237K 0.02% 609

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return